Encompass Health Q4 adjusted EPS rises 24.8% to USD 1.46

Reuters
02/06
Encompass Health Q4 adjusted EPS rises 24.8% to USD 1.46

Encompass Health Corporation reported its results for the fourth quarter (Q4) of 2025. Net operating revenue for Q4 2025 was USD 1.54 billion, reflecting a 9.9% increase. Net income attributable to shareholders for the period was USD 146.1 million. Diluted earnings per share from continuing operations reached USD 1.42, with a 20.3% increase, while adjusted earnings per share were USD 1.46, up by 24.8%. Cash flows provided by operating activities for the quarter totaled USD 346.0 million. The company also issued its 2026 guidance, projecting adjusted earnings per share attributable to Encompass Health in the range of USD 5.81 to USD 6.10. Supplemental information and additional details regarding the quarter and outlook are available on the company’s investor relations website. Encompass Health remains the largest owner and operator of inpatient rehabilitation hospitals in the United States.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Encompass Health Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CL80977) on February 05, 2026, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10